Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Hill-Rom opened its Asia-Pacific center in Singapore

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to...

The National Health Service is moving forward with plans...
Hill-Rom has formally opened its Asia-Pacific Innovation Center in Singapore. Today, the company hosted an event to commemorate the opening.

Hill-Rom has formally opened its Asia-Pacific Innovation Center in Singapore. Today, the company hosted an event to commemorate the opening. Peter H. Soderberg, president and CEO of Hill-Rom said, Hill-Rom is pleased to celebrate the opening of this important addition to our global R&D footprint. Our Innovation Center in Singapore represents an acceleration of our efforts to embed increasingly sophisticated and differentiated micro-electronics and software in our products.  We also see the opening of this Center as an important step in globalizing our products and presence.

The Asia-Pacific Innovation Center is now the home base for new Hill-Rom teams focused on research & development projects for global applications of various Hill-Rom products. Teams in Singapore are developing projects that involve microelectronics, embedded software, and electro-mechanical systems. These projects are integral to the technical development of new Hill-Rom beds and therapy surfaces.

Abel Ang, chief technology officer for Hill-Rom said, Innovation and partnering are key levers for a successful medical technology company like Hill-Rom. That's why we saw Singapore as a perfect location. Not only does Singapore offer great technical talent, but also it provides an environment with sophisticated health care institutions and a strong government supportive of growth.  As our R&D Center ramps up, we are looking to collaborate with our Asian partners to advance and test new bed technologies and business models with the intent of raising the standard of care offered to patients and caregivers worldwide.

Soderberg explained that Hill-Rom has an ongoing commitment to its home base in Indiana but also recognizes the need to leverage opportunities in the Asia-Pacific region as well as to tap into the talents and strengths of a global workforce. Singapore, with its regional reputation for advancing technology development and innovation, its similarities to North America in terms of its health care environment and its proximity to the broader Asia-Pacific region made it a natural choice.

The Hill-Rom Asia-Pacific Innovation Center in Singapore now includes 11,000 square feet of space built out as offices, research and development labs and a customer experience center. In addition to the R&D staff, this location is the home to sales and marketing staff in the region.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป